Semaglutide mimics a hormone that targets areas of the brain regulating appetite and food intake.
15%
Average weight loss
68 weeks
Clinical trial duration
FDA
Approved treatment
"GLP-1s are transforming how we treat obesity. The results I see with my patients are remarkable."
Dr. Sarah Chen, MD
Board Certified Endocrinologist
Select your primary health goal